Cardiac ankyrins in health and disease

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 2, 2009, Pages 203-209

  Hashemi, Seyed M ^a   Hund, Thomas J ^a   Mohler, Peter J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Ankyrin; Arrhythmia; Cytoskeleton; Targeting; Trafficking

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANKYRIN; ANKYRIN B; ANKYRIN G; OBSCURIN; PHOSPHOPROTEIN PHOSPHATASE 2A; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

AMINO ACID SUBSTITUTION; BRUGADA SYNDROME; CARDIOVASCULAR DISEASE; GENETIC VARIABILITY; HEART ARRHYTHMIA; HEART AUTOMATICITY; HEART DISEASE; HEART INFARCTION; HUMAN; LONG QT SYNDROME; MEMBRANE STRUCTURE; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SICK SINUS SYNDROME; SINUS NODE DISEASE; SUDDEN DEATH;

ANKYRINS; BRUGADA SYNDROME; DISEASE; HEALTH; HUMANS; MYOCARDIUM; SINOATRIAL NODE;

ANIMALIA;

EID: 67649099325     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.04.010     Document Type: Review

References (113)

1. Ayalon G., Davis J.Q., Scotland P.B., and Bennett V. An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. Cell 135 7 (2008) 1189-1200
2. Kizhatil K., Baker S.A., Arshavsky V.Y., and Bennett V. Ankyrin-G promotes cyclic nucleotide-gated channel transport to rod photoreceptor sensory cilia. Science 323 5921 (2009) 1614-1617
3. Kizhatil K., Sandhu N.K., Peachey N.S., and Bennett V. Ankyrin-B is required for coordinated expression of beta-2-spectrin, the Na/K-ATPase and the Na/Ca exchanger in the inner segment of rod photoreceptors. Exp. Eye Res. 88 1 (2009) 57-64
4. Bennett V., and Baines A.J. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol. Rev. 81 3 (2001) 1353-1392
5. Bennett V. Purification of an active proteolytic fragment of the membrane attachment site for human erythrocyte spectrin. J. Biol. Chem. 253 7 (1978) 2292-2299
6. Eber S.W., Gonzalez J.M., Lux M.L., Scarpa A.L., Tse W.T., Dornwell M., et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat. Genet. 13 2 (1996) 214-218
7. 2+ exchanger binds to the cytoskeletal protein ankyrin. J. Biol. Chem. 268 16 (1993) 11489-11491
8. Mohler P.J., Gramolini A.O., and Bennett V. The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes. J. Biol. Chem. 277 12 (2002) 10599-10607
9. 2+ release. J. Biol. Chem. 270 13 (1995) 7257-7260
10. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421 6923 (2003) 634-639
11. Mohler P.J., Davis J.Q., Davis L.H., Hoffman J.A., Michaely P., and Bennett V. Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B. J. Biol. Chem. 279 13 (2004) 12980-12987
12. v1.5 on the surface of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 101 50 (2004) 17533-17538
13. Mohler P.J., Davis J.Q., and Bennett V. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP(3) receptor in a cardiac T-tubule/SR microdomain. PLoS Biol. 3 12 (2005) e423
14. Bhasin N., Cunha S.R., Mudannayake M., Gigena M.S., Rogers T.B., and Mohler P.J. Molecular basis for PP2A regulatory subunit B56{alpha} targeting in cardiomyocytes. Am. J. Physiol., Heart Circ. Physiol. 293 1 (2007) H109-H119
15. Cunha S.R., Bhasin N., and Mohler P.J. Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B. J. Biol. Chem. 282 7 (2007) 4875-4883
16. Lowe J.S., Palygin O., Bhasin N., Hund T.J., Boyden P.A., Shibata E., et al. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway. J. Cell Biol. 180 1 (2008) 173-186
17. Le Scouarnec S., Bhasin N., Vieyres C., Hund T.J., Cunha S.R., Koval O., et al. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc. Natl. Acad. Sci. U. S. A. 105 40 (2008) 15617-15622
18. Cunha S.R., and Mohler P.J. Cardiac ankyrins: essential components for development and maintenance of excitable membrane domains in heart. Cardiovasc. Res. 71 1 (2006) 22-29
19. Cunha S.R., Le Scouarnec S., Schott J.J., and Mohler P.J. Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease. J. Mol. Cell. Cardiol. 45 6 (2008) 724-734
20. Kunimoto M. A neuron-specific isoform of brain ankyrin, 440-kD ankyrinB, is targeted to the axons of rat cerebellar neurons. J. Cell Biol. 131 6 Pt 2 (1995) 1821-1829
21. Kontrogianni-Konstantopoulos A., Jones E.M., Van Rossum D.B., and Bloch R.J. Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol. Biol. Cell 14 3 (2003) 1138-1148
22. Kontrogianni-Konstantopoulos A., and Bloch R.J. The hydrophilic domain of small ankyrin-1 interacts with the two N-terminal immunoglobulin domains of titin. J. Biol. Chem. 278 6 (2003) 3985-3991
23. Bagnato P., Barone V., Giacomello E., Rossi D., and Sorrentino V. Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles. J. Cell Biol. 160 2 (2003) 245-253
24. Zhou D., Birkenmeier C.S., Williams M.W., Sharp J.J., Barker J.E., and Bloch R.J. Small, membrane-bound, alternatively spliced forms of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle. J. Cell Biol. 136 3 (1997) 621-631
25. Birkenmeier C.S., Sharp J.J., Gifford E.J., Deveau S.A., and Barker J.E. An alternative first exon in the distal end of the erythroid ankyrin gene leads to production of a small isoform containing an NH2-terminal membrane anchor. Genomics 50 1 (1998) 79-88
26. Gallagher P.G., and Forget B.G. An alternate promoter directs expression of a truncated, muscle-specific isoform of the human ankyrin 1 gene. J. Biol. Chem. 273 3 (1998) 1339-1348
27. Cunha S.R., and Mohler P.J. Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. J. Biol. Chem. 283 46 (2008) 31968-31980
28. Mohler P.J., Splawski I., Napolitano C., Bottelli G., Sharpe L., Timothy K., et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc. Natl. Acad. Sci. U. S. A. 101 24 (2004) 9137-9142
29. Mohler P.J., Gramolini A.O., and Bennett V. Ankyrins. J. Cell. Sci. 115 Pt 8 (2002) 1565-1566
30. +) ATPase and implications for the organization of membrane domains in polarized cells. Nature 328 6130 (1987) 533-536
31. Koob R., Zimmermann M., Schoner W., and Drenckhahn D. Colocalization and coprecipitation of ankyrin and Na+,K+-ATPase in kidney epithelial cells. Eur. J. Cell Biol. 45 2 (1988) 230-237
32. Morrow J.S., Cianci C.D., Ardito T., Mann A.S., and Kashgarian M. Ankyrin links fodrin to the alpha subunit of Na,K-ATPase in Madin-Darby canine kidney cells and in intact renal tubule cells. J. Cell Biol. 108 2 (1989) 455-465
33. Devaux J., Alcaraz G., Grinspan J., Bennett V., Joho R., Crest M., et al. Kv3.1b is a novel component of CNS nodes. J. Neurosci. 23 11 (2003) 4509-4518
34. Lopez C., Metral S., Eladari D., Drevensek S., Gane P., Chambrey R., et al. The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells. J. Biol. Chem. 280 9 (2005) 8221-8228
35. - anion exchanger. J. Biol. Chem. 270 52 (1995) 31298-31302
36. Michaely P., and Bennett V. The ANK repeats of erythrocyte ankyrin form two distinct but cooperative binding sites for the erythrocyte anion exchanger. J. Biol. Chem. 270 37 (1995) 22050-22057
37. Bennett V., and Stenbuck P.J. Identification and partial purification of ankyrin, the high affinity membrane attachment site for human erythrocyte spectrin. J. Biol. Chem. 254 7 (1979) 2533-2541
38. Bodine D.M.t., Birkenmeier C.S., and Barker J.E. Spectrin deficient inherited hemolytic anemias in the mouse: characterization by spectrin synthesis and mRNA activity in reticulocytes. Cell 37 3 (1984) 721-729
39. Liu S.C., Derick L.H., Agre P., and Palek J. Alteration of the erythrocyte membrane skeletal ultrastructure in hereditary spherocytosis, hereditary elliptocytosis, and pyropoikilocytosis. Blood 76 1 (1990) 198-205
40. Hanspal M., Yoon S.H., Yu H., Hanspal J.S., Lambert S., Palek J., et al. Molecular basis of spectrin and ankyrin deficiencies in severe hereditary spherocytosis: evidence implicating a primary defect of ankyrin. Blood 77 1 (1991) 165-173
41. Jenkins S.M., and Bennett V. Ankyrin-G coordinates assembly of the spectrin-based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at Purkinje neuron initial segments. J. Cell Biol. 155 5 (2001) 739-746
42. Kizhatil K., and Bennett V. Lateral membrane biogenesis in human bronchial epithelial cells requires 190-kDa ankyrin-G. J. Biol. Chem. 279 16 (2004) 16706-16714
43. Yang Y., Ogawa Y., Hedstrom K.L., and Rasband M.N. betaIV spectrin is recruited to axon initial segments and nodes of Ranvier by ankyrinG. J. Cell Biol. 176 4 (2007) 509-519
44. Yang Y., Lacas-Gervais S., Morest D.K., Solimena M., and Rasband M.N. BetaIV spectrins are essential for membrane stability and the molecular organization of nodes of Ranvier. J. Neurosci. 24 33 (2004) 7230-7240
45. Davis L.H., Davis J.Q., and Bennett V. Ankyrin regulation: an alternatively spliced segment of the regulatory domain functions as an intramolecular modulator. J. Biol. Chem. 267 26 (1992) 18966-18972
46. Hall T.G., and Bennett V. Regulatory domains of erythrocyte ankyrin. J. Biol. Chem. 262 22 (1987) 10537-10545
47. Mohler P.J., Hoffman J.A., Davis J.Q., Abdi K.M., Kim C.R., Jones S.K., et al. Isoform specificity among ankyrins: an amphipathic alpha-helix in the divergent regulatory domain of ankyrin-B interacts with the molecular co-chaperone Hdj1/Hsp40. J. Biol. Chem. 279 24 (2004) 25798-25804
48. Abdi K.M., Mohler P.J., Davis J.Q., and Bennett V. Isoform specificity of ankyrin-B: a site in the divergent c-terminal domain is required for intramolecular association. J. Biol. Chem. 281 9 (2006) 5741-5749
49. Mohler P.J., Le Scouarnec S., Denjoy I., Lowe J.S., Guicheney P., Caron L., et al. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation 115 4 (2007) 432-441
50. Borzok M.A., Catino D.H., Nicholson J.D., Kontrogianni-Konstantopoulos A., and Bloch R.J. Mapping the binding site on small ankyrin 1 for obscurin. J. Biol. Chem. 282 44 (2007) 32384-32396
51. Del Rio M., Imam A., DeLeon M., Gomez G., Mishra J., Ma Q., et al. The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia. J. Am. Soc. Nephrol. 15 1 (2004) 41-51
52. Kizhatil K., Davis J.Q., Davis L., Hoffman J., Hogan B.L., and Bennett V. Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. J Biol Chem 282 36 (2007) 26552-26561
53. Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S., Robinson J.L., et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102 10 (2000) 1178-1185
54. + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 92 12 (1995) 3381-3386
55. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., and Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 5 (1995) 795-803
56. Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M., VanRaay T.J., et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12 1 (1996) 17-23
57. Wang Q., Shen J., Li Z., Timothy K., Vincent G.M., Priori S.G., et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum. Mol. Genet. 4 9 (1995) 1603-1607
58. Schott J.J., Charpentier F., Peltier S., Foley P., Drouin E., Bouhour J.B., et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am. J. Hum. Genet. 57 5 (1995) 1114-1122
59. Berlin J.R., Cannell M.B., and Lederer W.J. Cellular origins of the transient inward current in cardiac myocytes. Role of fluctuations and waves of elevated intracellular calcium. Circ. Res. 65 1 (1989) 115-126
60. Schlotthauer K., and Bers D.M. Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials. Circ. Res. 87 9 (2000) 774-780
61. Egdell R.M., De Souza A.I., and Macleod K.T. Relative importance of SR load and cytoplasmic calcium concentration in the genesis of aftercontractions in cardiac myocytes. Cardiovasc. Res. 47 4 (2000) 769-777
62. Mank-Seymour A.R., Richmond J.L., Wood L.S., Reynolds J.M., Fan Y.T., Warnes G.R., et al. Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes. Am. Heart J. 152 6 (2006) 1116-1122
63. Sherman J., Tester D.J., and Ackerman M.J. Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects. Heart Rhythm 2 11 (2005) 1218-1223
64. Mangrum J.M., and DiMarco J.P. The evaluation and management of bradycardia. N. Engl. J. Med. 342 10 (2000) 703-709
65. Lev M. Aging changes in the human sinoatrial node. J. Gerontol. 9 1 (1954) 1-9
66. Bernstein A.D., and Parsonnet V. Survey of cardiac pacing in the United States in 1989. Am. J. Cardiol. 69 4 (1992) 331-338
67. Demoulin J.C., and Kulbertus H.E. Histopathological correlates of sinoatrial disease. Br. Heart J. 40 12 (1978) 1384-1389
68. Benson D.W., Wang D.W., Dyment M., Knilans T.K., Fish F.A., Strieper M.J., et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112 7 (2003) 1019-1028
69. Smits J.P., Koopmann T.T., Wilders R., Veldkamp M.W., Opthof T., Bhuiyan Z.A., et al. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J. Mol. Cell. Cardiol. 38 6 (2005) 969-981
70. Ueda K., Nakamura K., Hayashi T., Inagaki N., Takahashi M., Arimura T., et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J. Biol. Chem. 279 26 (2004) 27194-27198
71. Klein G., Schroder F., Vogler D., Schaefer A., Haverich A., Schieffer B., et al. Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. role of phosphatase 2A. Cardiovasc. Res. 59 1 (2003) 37-45
72. De Arcangelis V., Soto D., and Xiang Y. Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor. Mol. Pharmacol. 74 5 (2008) 1453-1462
73. 2+ channel Cav1.2. Science 293 5527 (2001) 98-101
74. Davare M.A., Horne M.C., and Hell J.W. Protein phosphatase 2A is associated with class C L-type calcium channels (Cav1.2) and antagonizes channel phosphorylation by cAMP-dependent protein kinase. J. Biol. Chem. 275 50 (2000) 39710-39717
75. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 4 (2000) 365-376
76. DeSouza N., Reiken S., Ondrias K., Yang Y.M., Matkovich S., and Marks A.R. Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex. J. Biol. Chem. 277 42 (2002) 39397-39400
77. Lecuona E., Dada L.A., Sun H., Butti M.L., Zhou G., Chew T.L., et al. Na,K-ATPase alpha1-subunit dephosphorylation by protein phosphatase 2A is necessary for its recruitment to the plasma membrane. FASEB J. 20 14 (2006) 2618-2620
78. Borisov A.B., Raeker M.O., Kontrogianni-Konstantopoulos A., Yang K., Kurnit D.M., Bloch R.J., et al. Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth. Biochem. Biophys. Res. Commun. 310 3 (2003) 910-918
79. Borisov A.B., Sutter S.B., Kontrogianni-Konstantopoulos A., Bloch R.J., Westfall M.V., and Russell M.W. Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing. Histochem. Cell Biol. 125 3 (2006) 227-238
80. 2+ release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56{alpha} and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res. 104 (2009) 514-521
81. Hund T.J., Wright P.J., Dun W., Snyder J.S., Boyden P.A., and Mohler P.J. Regulation of the ankyrin-B-based targeting pathway following myocardial infarction. Cardiovasc. Res. 81 4 (2009) 742-749
82. Janse M.J., and Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69 4 (1989) 1049-1169
83. Pinto J.M., and Boyden P.A. Electrical remodeling in ischemia and infarction. Cardiovasc. Res. 42 2 (1999) 284-297
84. Baba S., Dun W., Cabo C., and Boyden P.A. Remodeling in cells from different regions of the reentrant circuit during ventricular tachycardia. Circulation 112 16 (2005) 2386-2396
85. + currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ. Res. 81 1 (1997) 110-119
86. Priori S.G., Bloise R., and Crotti L. The long QT syndrome. Europace 3 1 (2001) 16-27
87. Priori S.G., Napolitano C., and Schwartz P.J. Electrophysiologic mechanisms involved in the development of torsades de pointes. Cardiovasc. Drugs Ther./sponsored by the Int. Soc. Cardiovasc. Pharmacother. 5 1 (1991) 203-212
88. Gaita F., Giustetto C., Bianchi F., Wolpert C., Schimpf R., Riccardi R., et al. Short QT syndrome: a familial cause of sudden death. Circulation 108 8 (2003) 965-970
89. Keating M.T., and Sanguinetti M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104 4 (2001) 569-580
90. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J.L., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 5 (1995) 805-811
91. Pfeufer A., Jalilzadeh S., Perz S., Mueller J.C., Hinterseer M., Illig T., et al. Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ. Res. 96 6 (2005) 693-701
92. Sedlacek K., Stark K., Cunha S.R., Pfeufer A., Weber S., Berger I., et al. Common genetic variants in ANK2 modulate QT interval: results from the KORA study. Circulation: Cardiovasc. Genet. 1 2 (2008) 93-99
93. Akyol M., Jalilzadeh S., Sinner M.F., Perz S., Beckmann B.M., Gieger C., et al. The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study. Eur. Heart J. 28 3 (2007) 305-309
94. Arking D.E., Pfeufer A., Post W., Kao W.H., Newton-Cheh C., Ikeda M., et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat. Genet. 38 6 (2006) 644-651
95. Bennett P.B., Yazawa K., Makita N., and George Jr. A.L. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376 6542 (1995) 683-685
96. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 6673 (1998) 293-296
97. Schott J.J., Alshinawi C., Kyndt F., Probst V., Hoorntje T.M., Hulsbeek M., et al. Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet. 23 1 (1999) 20-21
98. Zhou D., Lambert S., Malen P.L., Carpenter S., Boland L.M., and Bennett V. AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J. Cell Biol. 143 5 (1998) 1295-1304
99. Jenkins S.M., and Bennett V. Developing nodes of Ranvier are defined by ankyrin-G clustering and are independent of paranodal axoglial adhesion. Proc. Natl. Acad. Sci. U. S. A. 99 4 (2002) 2303-2308
100. + channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kD protein. Neuron 3 2 (1989) 163-175
101. Kordeli E., Ludosky M.A., Deprette C., Frappier T., and Cartaud J. AnkyrinG is associated with the postsynaptic membrane and the sarcoplasmic reticulum in the skeletal muscle fiber. J. Cell. Sci. 111 Pt 15 (1998) 2197-2207
102. Wood S.J., and Slater C.R. beta-Spectrin is colocalized with both voltage-gated sodium channels and ankyrinG at the adult rat neuromuscular junction. J. Cell Biol. 140 3 (1998) 675-684
103. Kordeli E., Lambert S., and Bennett V. AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. J. Biol. Chem. 270 5 (1995) 2352-2359
104. Davis J.Q., Lambert S., and Bennett V. Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segments. J. Cell Biol. 135 5 (1996) 1355-1367
105. Pan Z., Kao T., Horvath Z., Lemos J., Sul J.Y., Cranstoun S.D., et al. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J. Neurosci. 26 10 (2006) 2599-2613
106. Hill A.S., Nishino A., Nakajo K., Zhang G., Fineman J.R., Selzer M.E., et al. Ion channel clustering at the axon initial segment and node of Ranvier evolved sequentially in early chordates. PLoS Genet. 4 12 (2008) e1000317
107. Garrido J.J., Giraud P., Carlier E., Fernandes F., Moussif A., Fache M.P., et al. A targeting motif involved in sodium channel clustering at the axonal initial segment. Science 300 5628 (2003) 2091-2094
108. Lemaillet G., Walker B., and Lambert S. Identification of a conserved ankyrin-binding motif in the family of sodium channel alpha subunits. J. Biol. Chem. 278 30 (2003) 27333-27339
109. Antzelevitch C., Brugada P., Borggrefe M., Brugada J., Brugada R., Corrado D., et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2 4 (2005) 429-440
110. Priori S.G. Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circ. Res. 94 2 (2004) 140-145
111. Priori S.G., and Napolitano C. Genetics of cardiac arrhythmias and sudden cardiac death. Ann. N.Y. Acad. Sci. 1015 (2004) 96-110
112. Smits J.P., Eckardt L., Probst V., Bezzina C.R., Schott J.J., Remme C.A., et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J. Am. Coll. Cardiol. 40 2 (2002) 350-356
113. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della Bella P., Giordano U., et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105 11 (2002) 1342-1347